HbA1c as a shared treatment goal in type 2 diabetes? A secondary analysis of the DEBATE trial
CONCLUSIONS: Shared goal setting with T2DM patients targeting on HbA1c-levels had no significant impact on goal achievement. It may be assumed, that shared goal setting on patient-related clinical outcomes within the process of SDM has not been fully captured yet.TRIAL REGISTRATION: The trial was registered at ISRCTN registry under the reference ISRCTN70713571.PMID:37173620 | PMC:PMC10182591 | DOI:10.1186/s12875-023-02067-9
Source: Primary Care - Category: Primary Care Authors: Sara Santos Michael Pentzek Attila Altiner Anne Daubmann Eva Drewelow Christian Helbig Christin L öffler Susanne L öscher Karl Wegscheider Heinz-Harald Abholz Stefan Wilm Anja Wollny Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Education | Endocrinology | Germany Health | Insulin | Primary Care | Universities & Medical Training